R&D How Design of Experiments enriches life sciences’ findings Design of Experiments (DOE) is a methodology misunderstood by many, understood by some, and actively used by even fewer than that.
Oncology Following science to fruition, putting patients first: An AS... At ASCO25, AstraZeneca presented late-breaking data from the DESTINY-Breast09 Phase III trial. Alison Dziarmaga discussed the data with pharmaphorum.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face
